RIPK1 and multiple sclerosis: For noninfectious diseases, inhibition of the RIPK1-dependent necroptosis pathway can ameliorate ischemia-reperfusion injury in the brain, kidney, and heart [61] and alleviate retinal degeneration, brain impact trauma, ethanol-induced liver injury, multiple sclerosis, and tumor progression [37, 62].